IllinoisSB4068104th General Assembly (2025–2026)Senate

INS-PRIOR AUTH HIV DRUG ACCESS

Sponsored By: Sara Feigenholtz (Democratic)

In Committee

Summary

Amends the Illinois Insurance Code. Provides that, on and after the effective date of the amendatory Act, coverage for all abortifacients, hormonal therapy medication, human immunodeficiency virus pre-exposure prophylaxis, and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration, and follow-up services related to that coverage, shall include screenings for pre-PrEP HIV and sexually transmitted infections. Provides that the coverage shall also include kidney function analysis, routine laboratory testing, and routine provider visits associated with those screenings. Amends the Prior Authorization Reform Act. Prohibits a health insurance issuer from requiring prior authorization for the following prescription drug types and their therapeutic equivalents approved by the United States Food and Drug Administration: human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis medication or human immunodeficiency virus treatment medication. Effective January 1, 2028.

assignments

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Sara Feigenholtz

    Democratic • Senate

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Referred to Assignments

    2/24/2026Senate
  2. First Reading

    2/24/2026Senate
  3. Filed with Secretary by Sen. Sara Feigenholtz

    2/24/2026Senate

Bill Text

Related Bills

Back to State Legislation